Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA, NCL Launch “Take With Care” OTC Analgesic Safety Campaign

This article was originally published in The Tan Sheet

Executive Summary

FDA is "very seriously" looking into labeling changes for OTC pain relievers, according to outgoing Associate Commissioner for External Relations Peter Pitts
Advertisement

Related Content

Wyeth Expands GI Warnings For Junior Strength Advil, Orudis KT Labeling
Wyeth Expands GI Warnings For Junior Strength Advil, Orudis KT Labeling
Wyeth Expands GI Warnings For Junior Strength Advil, Orudis KT Labeling
Xtreme Tylenol: Wakeboarding, Olympics And Indie Film Festivals
FDA Analgesic Safety Campaign Launches; Label Warnings Still In Progress
NSAID Alcohol Warning Seldom Read By Heavy Drinkers – NCL Survey
Acetaminophen “Black Box” Warning Would “Scare” Users, NDAC Rep Says
Acetaminophen “Black Box” Warning Would “Scare” Users, NDAC Rep Says
Aspirin, NSAID GI Bleeding Language Could Replace Alcohol Warning
Voluntary Acetaminophen Labeling Revisions Include Overdose Warning

Topics

Advertisement
UsernamePublicRestriction

Register

PS096931

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel